【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 11
2 Introduction 12
2.1 Spinal Fusion Overview 12
3 Products under Development 13
3.1 Spinal Fusion – Pipeline Products by Stage of Development 13
3.2 Spinal Fusion – Pipeline Products by Segment 14
3.3 Spinal Fusion – Pipeline Products by Territory 15
3.4 Spinal Fusion – Pipeline Products by Regulatory Path 17
3.5 Spinal Fusion – Pipeline Products by Estimated Approval Date 18
3.6 Spinal Fusion – Ongoing Clinical Trials 19
4 Spinal Fusion – Pipeline Products under Development by Companies 20
4.1 Spinal Fusion Companies – Pipeline Products by Stage of Development 20
4.2 Spinal Fusion – Pipeline Products by Stage of Development 22
5 Spinal Fusion Companies and Product Overview 26
5.1 4-Web Spine, LLC Company Overview 26
5.1.1 4-Web Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 26
5.2 Alphatec Holdings, Inc. Company Overview 30
5.2.1 Alphatec Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.3 Amedica Corporation Company Overview 41
5.3.1 Amedica Corporation Pipeline Products & Ongoing Clinical Trials Overview 41
5.4 APTO Orthopaedics Company Overview 43
5.4.1 APTO Orthopaedics Pipeline Products & Ongoing Clinical Trials Overview 43
5.5 Aurora Spine Corporation Company Overview 44
5.5.1 Aurora Spine Corporation Pipeline Products & Ongoing Clinical Trials Overview 44
5.6 Bio2 Technologies, Inc. Company Overview 49
5.6.1 Bio2 Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.7 Bonovo Orthopedics, Inc. Company Overview 51
5.7.1 Bonovo Orthopedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.8 Cortical Concepts (Inactive) Company Overview 53
5.8.1 Cortical Concepts (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 53
5.9 DiFusion Technologies Inc. Company Overview 54
5.9.1 DiFusion Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.10 ECA Medical Instruments, Inc. Company Overview 56
5.10.1 ECA Medical Instruments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
5.11 Eden Spine, LLC Company Overview 58
5.11.1 Eden Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 58
5.12 Eminent Spine, LLC Company Overview 63
5.12.1 Eminent Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 63
5.13 Exactech, Inc. Company Overview 66
5.13.1 Exactech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.14 Expanding Orthopedics Inc. Company Overview 68
5.14.1 Expanding Orthopedics Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
5.15 Globus Medical, Inc. Company Overview 72
5.15.1 Globus Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
5.16 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 76
5.16.1 H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
5.17 Implants International Limited Company Overview 77
5.17.1 Implants International Limited Pipeline Products & Ongoing Clinical Trials Overview 77
5.18 Integra LifeSciences Holdings Corporation Company Overview 79
5.18.1 Integra LifeSciences Holdings Corporation Pipeline Products & Ongoing Clinical Trials Overview 79
5.19 Intelligent Implant Systems, LLC Company Overview 81
5.19.1 Intelligent Implant Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 81
5.20 Intrinsic Therapeutics, Inc. Company Overview 83
5.20.1 Intrinsic Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
5.21 Jemo Spine, LLC. Company Overview 86
5.21.1 Jemo Spine, LLC. Pipeline Products & Ongoing Clinical Trials Overview 86
5.22 Kspine, Inc. Company Overview 87
5.22.1 Kspine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 87
5.23 Medtronic plc Company Overview 88
5.23.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 88
5.24 MicroPort Scientific Corporation Company Overview 92
5.24.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 92
5.25 Nasseo, Inc. Company Overview 95
5.25.1 Nasseo, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.26 NLT SPINE Company Overview 96
5.26.1 NLT SPINE Pipeline Products & Ongoing Clinical Trials Overview 96
5.27 NuVasive, Inc. Company Overview 99
5.27.1 NuVasive, Inc. Pipeline Products & Ongoing Clinical Trials Overview 99
5.28 OsteoGeneX Inc. Company Overview 104
5.28.1 OsteoGeneX Inc. Pipeline Products & Ongoing Clinical Trials Overview 104
5.29 OsteoVantage, Inc. Company Overview 107
5.29.1 OsteoVantage, Inc. Pipeline Products & Ongoing Clinical Trials Overview 107
5.30 Paradigm Spine, LLC Company Overview 108
5.30.1 Paradigm Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 108
5.31 Pharmaco-Kinesis Corporation Company Overview 109
5.31.1 Pharmaco-Kinesis Corporation Pipeline Products & Ongoing Clinical Trials Overview 109
5.32 Spinal Balance Inc. Company Overview 110
5.32.1 Spinal Balance Inc. Pipeline Products & Ongoing Clinical Trials Overview 110
5.33 Spinal Simplicity, LLC Company Overview 113
5.33.1 Spinal Simplicity, LLC Pipeline Products & Ongoing Clinical Trials Overview 113
5.34 SpinalVu Inc Company Overview 114
5.34.1 SpinalVu Inc Pipeline Products & Ongoing Clinical Trials Overview 114
5.35 Spine Smith, LP Company Overview 116
5.35.1 Spine Smith, LP Pipeline Products & Ongoing Clinical Trials Overview 116
5.36 Spine Wave, Inc. Company Overview 118
5.36.1 Spine Wave, Inc. Pipeline Products & Ongoing Clinical Trials Overview 118
5.37 SpineAlign Medical, Inc. Company Overview 119
5.37.1 SpineAlign Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 119
5.38 SpineCraft, LLC Company Overview 120
5.38.1 SpineCraft, LLC Pipeline Products & Ongoing Clinical Trials Overview 120
5.39 SpineGuard, S.A. Company Overview 122
5.39.1 SpineGuard, S.A. Pipeline Products & Ongoing Clinical Trials Overview 122
5.40 Spineology Inc. Company Overview 124
5.40.1 Spineology Inc. Pipeline Products & Ongoing Clinical Trials Overview 124
5.41 Spineway Company Overview 127
5.41.1 Spineway Pipeline Products & Ongoing Clinical Trials Overview 127
5.42 Spinofix Inc Company Overview 129
5.42.1 Spinofix Inc Pipeline Products & Ongoing Clinical Trials Overview 129
5.43 The University of Utah Company Overview 133
5.43.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 133
5.44 University of South Florida Company Overview 134
5.44.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 134
5.45 Vexim SA Company Overview 138
5.45.1 Vexim SA Pipeline Products & Ongoing Clinical Trials Overview 138
5.46 X-spine Systems, Inc. Company Overview 141
5.46.1 X-spine Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 141
5.47 Zyga Technology, Inc. Company Overview 142
5.47.1 Zyga Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 142
6 Spinal Fusion – Recent Developments 145
7 Appendix 250
7.1 Methodology 250
7.2 About GlobalData 252
7.3 Contact Us 253
7.4 Disclaimer 253
【レポート販売概要】
■ タイトル:脊椎固定装置の世界市場:パイプラインレビュー2015■ 英文:Spinal Fusion - Pipeline Review, 2015
■ 発行日:2015年4月28日
■ 調査会社:GlobalData
■ 商品コード:GDME0007EPD
■ 調査対象地域:グローバル
- 肝性脳症(Hepatic Encephalopathy):世界の治験レビュー(2015年上半期版)Hepatic Encephalopathy Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hepatic Encephalopathy Global Clinical Trials Review, H1, 2015" provides data on the Hepatic Encephalopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatic Encephalopathy. It includes an overview of the trial numbers and …
- 医薬品受託製造・受託研究の世界市場分析:サービス別(CMO {API /バルク薬物、先端薬物送達完成製剤}}、CRO {腫瘍学、ワクチン、免疫学、心臓学、神経科学})、セグメント予測、2014-2025The global pharmaceutical contract manufacturing/contract research market is anticipated to reach USD 238.3 billion by 2025, according to a new report by Grand View Research, Inc. Impact on the volume of capacity that is required for production due to of increasing expression levels is anticipated to influence outsourcing industry. Increased cell densities as well as increase in expression of each …
- コールドプラズマの世界市場予測:産業別、用途別、レジーム別The global cold plasma market is projected to grow at a CAGR of 15.6%The global cold plasma market size is expected to reach USD 3.1 billion by 2024 from USD 1.5 billion in 2019, at a CAGR of 15.6% during the forecast period. The growth in this market is primarily attributed to the benefits of cold plasma, such as its environment-friendliness, innovations in textile production, growing food safety …
- データセンターバックアップ・リカバリソフトウェアの世界市場:データセンターオペレーター、通信サービスプロバイダー、インターネットコンテンツプロバイダー、政府、金融サービスプロバイダー、他のオペレーター種類Global Data Center Backup and Recovery Software Market: About this market Enterprises use data center backup and recovery software to replicate and archive data. It also enables data recovery during data center outages. Technavio’s data center backup and recovery software market analysis considers sales from the data center operators, communication services providers, internet content providers, g …
- 空港保安の世界市場分析:技術別(出入管理、サイバーセキュリティ、境界セキュリティ、スクリーニング、監視)、セグメント予測 -2022The global airport security market size is expected to reach USD 12.70 billion by 2022, according to a new report by Grand View Research, Inc. National security is of vital importance at critical infrastructures such as airports. In recent years, the policy and aim of many authorities has shifted from potential threat identification to deploying measures that prevent infiltration of any type of th …
- 不妊治療の世界市場2018-2022About Infertility Treatment Infertility is a medical condition, observed in both men and women. It is the inability of a person to reproduce naturally. The global infertility treatment market involves the various drugs, devices, and services provided to treat infertility. Technavio’s analysts forecast the global infertility treatment market to grow at a CAGR of 5.23% during the period 2018-2022. C …
- 世界の医用高分子市場2015The Global Medical Plastics Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Medical Plastics industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Medical Plastics market analysis is provided for the international markets including development trends, …
- 石油・ガス産業向けSCADAの世界市場About SCADA SCADA is an automation system that helps to acquire data from remote devices such as transmitters, pumps, and valves, installed in the field and provides control remotely from SCADA host software platform. It helps to turn on and off the devices according to the required process. It also has graphic displays, trending, alarming, and historical storage of data functionalities. Earlier, …
- 特殊検査の世界市場2019-2023About this market The increasing prevalence of chronic diseases, such as cancers, among individuals is fueling the demand for the early diagnosis of diseases to offer better patient care. Infections are increasingly caused by pathogens such as bacteria, viruses, fungi, and parasites, resulting in diseases such as hepatitis and herpes as well as urinary tract infections and bladder infections. Anat …
- 血液及びフローサイトメトリー検査のグローバル市場Complete report $24,500. DataPack (test volumes, sales forecasts, supplier shares) $15,900. “Hematology and Flow Cytometry: A Market Facing Regulatory and Competitive Challenges--Advances in Molecular Diagnostics, IT, and Growing Understanding of Immunologic Forces Regulating Systemic Diseases Will Profoundly Impact the Market” is Venture Planning Group’s new seven-cou …
- 世界におけるガラス繊維強化プラスチック(GFRP)企業の上位19社分析:航空、エネルギー、建設、海上、自動車、スポーツ用品用途The glass fibre composites market will experience growth in the near future across many sectors and industry applications. The glass fibre composites industry is a highly fragmented competitive sector resulting in many companies competing for market share. The glass fibre market is the largest of the three main composites markets and visiongain expects it to reach a value of $30.9bn in 2014. Altho …
- Ergot Alkaloids (片頭痛/Migraine):医薬品市場予測及び分析(~2023)Ergot Alkaloids (Migraine) - Forecast and Market Analysis to 2023 Summary The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature pr …
- 軽飛行機の世界市場2017-2021About Light AircraftA light aircraft is generally a one- to eight-seater aircraft, which has a maximum gross take-off weight of 12,500 lbs. Technavio’s analysts forecast the global light aircraft market to grow at a CAGR of 5.63% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the global light aircraft market for 2017-2021. T …
- 自動車用デジタルコクピットの世界市場2018-2022About this market The increasing introduction of holographic display is likely to push growth in the market. The automotive holographic display is the 3D image of the object that uses diffraction to create it. Leading companies are working to employ this display technology. This holographic display-based interactive experience is expected to give a seamless user experience with higher levels of co …
- 航空機エンジンMRO(メンテナンス、修理、オーバーホール)の世界市場About aircraft engine MRO In the aerospace industry, engine MRO is carried out at regular intervals after an aircraft reaches the certain flight hour or flight cycle. Engine MRO includes performing routine checks or major overhauls to maintain the condition of an aircraft engine as per the requirements of operators. Engine MRO overhaul work usually involves off-wing disassembly, inspection, repair …